Facet browsing currently unavailable
Page 1 of 1 results
Sort by: relevance publication year
Showing DOI matching
10.1016/j.urology.2004.10.033
Docetaxel-based chemotherapy as second-line treatment for paclitaxel-based chemotherapy-resistant hormone-refractory prostate cancer: A pilot study JOURNAL ARTICLE published March 2005 in Urology |